Finally, as the specific adaptor of TNFAIP1, BTBD9 was found to be expressed at low levels in lung cancer, leading to the dysregulation of CRL3BTBD9 and subsequent upregulation of TNFAIP1. Here, TNFAIP1 is linked to lung carcinoma.